New England Section of the American Urological Association

NEAUA Home NEAUA Home Past & Future Meetings Past & Future Meetings

Back to 2025 Abstracts


Readmissions and complications after same day discharge following robot-assisted laparoscopic prostatectomy in Iceland: A nationwide population-based study
Hjalti R. Snorrason, BSc.1, Edward Rumba, BSc.1, Helgi K. Engilbertsson, MD.2, Rafn Hilmarsson, MD.2, Johann P. Ingimarsson, MD.2.
1University of Iceland, Reykjavík, Iceland, 2Landspitali – The National University Hospital of Iceland, Reykjavík, Iceland.

Background: Same day discharge (SDD) after robot-assisted laparoscopic prostatectomy is the standard treatment process in Iceland, overtaking the conventional overnight hospital stay. This nationwide study evaluates success rate, complications and readmissions after SDD.
Methods: The study population involved 316 patients who underwent RALP between September 2019 and December 2023. Operational, clinical and oncological variables were collected retrospectively through manual chart review. Readmissions and complications within 30 days were recorded. Complications were listed in the Clavien-Dindo classification system. Variables were compared between SDD patients, logistically admitted patients and patients admitted due to medical complications.
Results: Of the total 316 patients, 261 (82.6%) were successfully discharged on the day of surgery. There was a significant difference between patients admitted due to medical complications and SDD patients, concerning complications and readmissions (21% vs. 4.6%; p=0.016). Other collected variables were comparable. There was no significant difference in complications and readmissions when SDD patients were compared with logistically admitted patients (4.6% vs. 2.8%; p>0.9). Complications classified as Clavien-Dindo 3b or above, were recorded in 4 patients (1.3%). There was one death recorded within 90 days from surgery, which was unrelated to operational or oncological complications.
Conclusion: The results suggest that SDD is a safe strategy. Major complications are rare, and the readmission rate is low.



Back to 2025 Abstracts